New class drug significantly reduces spine fracture risk in postmenopausal women with osteoporosis
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 show that in postmenopausal women with osteoporosis, 12 months of treatment with romosozumab is associated with large, rapid ...
Jun 15, 2017
0
8